Group 1 - CARBIOS has released its Interim report for the first half of 2025, which is available for shareholders and the financial community [1] - The company focuses on developing and industrializing biological technologies aimed at reinventing the lifecycle of plastics and textiles [2] - CARBIOS has two main technologies: PET biorecycling and PLA biodegradation, which are currently being scaled up to industrial and commercial levels [2] Group 2 - The industrial demonstration plant for biorecycling has been operational since 2021, with the construction of the world's first biorecycling plant expected to resume before the end of 2025, pending additional funding [2] - CARBIOS collaborates with major brands in the cosmetics, food, and apparel industries to enhance the recyclability and circularity of their products [2] - The company is part of the global community of B Corp™ certified companies, indicating a commitment to transforming business models for the common good [2]

Financial Results - The company reported a solid cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months, thanks to a cost-saving plan executed in the first half of 2025 [2][6] - Revenue for the first half of 2025 was €519,000, compared to €73,000 in the same period of 2024, indicating significant growth [12][27] - The current operating loss improved to €17.6 million from €20 million year-over-year, attributed to reduced operating expenses and increased revenues [14][15] Regulatory Environment Developments - A new decree in France provides financial incentives for incorporating recycled materials into products, offering a €1,000/ton bonus for using biorecycled plastics in sensitive-contact packaging [3][9] - This regulatory change is expected to accelerate customer adoption of CARBIOS' technology, allowing the company to supply high-quality recycled PET (r-PET) at a competitive price [3][9] Longlaville PET Biorecycling Plant Update - The construction of the Longlaville biorecycling plant is expected to resume before the end of 2025, contingent upon securing additional funding [6][9] - The plant is set to be commissioned in the second half of 2027, with significant progress made in securing public funding and interest from private investors [6][9][13] - Pre-sales of products from the future plant are progressing, supported by a favorable regulatory environment [7][9] Licensing and Technological Development - The company remains committed to the commercialization of licenses for its technology, supported by technological maturity and ongoing negotiations with various partners [10] - CARBIOS has secured a significant portion of its raw material supply and signed polymerization contracts, strengthening the project's industrial foundations [7][10] Cash Flow and Financial Position - The net cash consumption for the first half of 2025 was €18.1 million, a decrease from €102.1 million in 2024, reflecting improved cash management [19][30] - Cash and cash equivalents at the end of the period stood at €71.7 million, down from €89.8 million at the beginning of the period [19][30]

Core Insights - CARBIOS has signed a multi-year commercial agreement with Indorama Ventures for the supply of biorecycled monomers, which will be transformed into r-PET filaments for Michelin tires [1][7] - This agreement signifies a strategic commitment to convert complex PET waste into high-performance materials, leveraging CARBIOS' enzymatic recycling technology [2][4] - The partnership is part of CARBIOS' pre-commercialization efforts for its Longlaville plant, following recent sales contracts with global cosmetics leaders [3][4] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions for plastic and textile lifecycle management, with a mission to prevent pollution and promote a circular economy [6] - The company has operationalized its industrial demonstration plant for biorecycling since 2021 and plans to resume construction of the world's first biorecycling plant in the second half of 2025, pending additional funding [6] - Indorama Ventures is a leading sustainable petrochemicals producer with a revenue of $15.4 billion in 2024, focusing on innovative and circular materials across various essential markets [9] - Michelin, a global leader in engineered materials, aims to integrate enzymatically recycled r-PET into its products as part of its commitment to achieving 100% renewable and recycled materials by 2050 [10]

Company Overview - CARBIOS is a biotech company focused on developing and industrializing biological solutions to reinvent the life cycle of plastics and textiles, aiming to reduce pollution and promote a circular economy [4]. - The company has two main technologies: biorecycling of PET and biodegradation of PLA, both of which are reaching industrial and commercial scales [4]. - CARBIOS has been recognized scientifically, including features in prestigious publications like Nature, and collaborates with major brands in various industries to enhance product recyclability [4]. Liquidity Contract and Financial Performance - As of June 30, 2025, CARBIOS reported assets on its liquidity account as part of a contract with Natixis ODDO BHF [2][3]. - The liquidity contract is in accordance with the French Financial Market Authority's regulations established in June 2021 [3]. - For the first half of 2025, the company executed 2,381 buy transactions totaling €2,121,620.77 for 324,721 shares, while sell transactions totaled €2,170,808.76 for 330,062 shares [5][11]. Future Developments - Construction of the world's first industrial biorecycling plant is expected to restart in the second half of 2025, contingent on securing additional funding [4]. - The biorecycling demonstration plant has been operational since 2021, showcasing CARBIOS's commitment to advancing its technologies [4].

Core Points - CARBIOS, a pioneer in biological technologies for plastics and textiles, held its Ordinary and Extraordinary General Meeting on June 19, 2025, where all resolutions were approved except for the 21st Resolution [1][2]. Company Updates - The renewal of the term of office for several directors, including representatives from Business Opportunities for L'Oréal Development (BOLD) and Michelin Ventures, was approved [3]. - Resignations were submitted by Mr. Juan de Pablo, Ms. Amandine de Souza, and Ms. Sandrine Conseiller, effective from the close of the Annual General Meeting and June 20, 2025, respectively [4][5]. - The Board of Directors will consist of 7 directors, including 3 independent directors and one non-voting director starting June 20, 2025 [5]. New Appointments - Ms. Julie Sonies is proposed to be co-opted as an independent director to replace Ms. Sandrine Conseiller at the next Board meeting scheduled for July 1, 2025 [6]. - Ms. Sonies has over 20 years of experience in finance and investment banking, having held significant positions at various prestigious firms [7]. Company Overview - CARBIOS focuses on developing biological solutions to reinvent the life cycle of plastics and textiles, aiming to reduce pollution and promote a circular economy [8]. - The company has two main technologies for biorecycling PET and biodegrading PLA, with its biorecycling demonstration plant operational since 2021 [8]. - Construction of the world's first industrial biorecycling plant is expected to restart in the second half of 2025, pending additional funding [8].

Core Insights - CARBIOS has signed its first multi-year offtake contracts with L'ORÉAL and L'Occitane en Provence for biorecycled r-PET from its upcoming commercial plant in Longlaville, marking a significant step in its strategy to industrialize biological technologies for plastic recycling [1][5]. Company Developments - The contracts with L'ORÉAL and L'Occitane confirm the demand for recycled and recyclable PET from enzymatic recycling, aligning with the brands' circularity and quality objectives for packaging [2][5]. - CARBIOS aims to achieve its sales and supply targets, expressing confidence in signing additional contracts for its Longlaville site soon [3][5]. - The company’s biorecycling demonstration plant has been operational since 2021, and construction of the world's first industrial biorecycling plant is expected to restart between June and September 2025, pending additional funding [4]. Industry Context - The partnership with CARBIOS is seen as a decisive step for L'Occitane en Provence in enhancing circularity in packaging, reflecting a broader commitment to reducing environmental impact within the industry [3]. - The contracts highlight the growing market for high-quality, recycled PET derived from enzymatic recycling, indicating a shift towards sustainable practices in the packaging industry [2][5].

Clermont-Ferrand (France), May 2, 2025 (6:00 pm CEST). CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces to its shareholders and the financial community that its 2024 Universal Registration Document including the annual report, the management report and the report on corporate governance was filed with the French Financial Market Authority (Autorité des marchés financiers) on Ap ...

Core Insights - CARBIOS reported its operating and financial results for the financial year 2024, highlighting a strategic focus on financing and technology sales to support the construction of its Longlaville plant [1][2]. Financial Performance - The Group's income for 2024 was €136 thousand, a significant increase from €24 thousand in 2023, primarily from feasibility studies and CARBIOS Active product deliveries [14][28]. - Operating expenses rose to €37,643 thousand in 2024 from €28,902 thousand in 2023, driven by increased personnel costs and external consulting services [14][21]. - The net loss for the period was €33,113 thousand, compared to a loss of €27,224 thousand in 2023, reflecting intensified commercial efforts and R&D activities [17][28]. Cash Position and Financing - As of December 31, 2024, CARBIOS had €109 million in cash, which includes €90 million in cash and cash equivalents [19][29]. - The company plans to finance its plant project through available cash, public grants of €42.5 million, and additional non-dilutive financing discussions, including potential government support for a debt guarantee of up to €86 million [4][6]. Operational Updates - The construction schedule for the Longlaville plant has been postponed by 6 to 9 months, with plans to resume once additional financing is secured [7][6]. - Significant progress has been made towards signing binding commercial contracts in the first half of 2025, alongside ongoing negotiations for licensing agreements [6][5]. Sustainability and Certifications - CARBIOS achieved B Corp™ label and ISO 9001 & 14001 certifications, with an improved extra-financial rating of 83/100 from EthiFinance [9]. - The company is focused on developing enzyme-based processes for biorecycling PET plastics and polyester fibers, contributing to the circular economy [22]. Patent Portfolio - CARBIOS strengthened its intellectual property portfolio with 58 patent families and 502 titles, including 28 new patents granted in key countries [10]. Organizational Changes - A reorganization and cost-cutting plan was initiated, potentially affecting around 40% of positions to ensure the implementation of its industrial and commercial strategy [11].